A New Promising Combination Immunotherapy Trial: Autologous Cancer Vaccine with Immune Checkpoint Inhibitor (K9-ACV + ICI)

A new chemotherapy trial is enrolling dogs with hemangiosarcoma. The study uses Paccal Vet, a safer formulation of paclitaxel designed specifically for dogs to reduce side effects while targeting aggressive cancer.

EGFR vaccine helped Dennis overcome osteosarcoma without losing his leg.